Cargando…

PB1731: INOTUZUMAB OZOGAMICIN IN LYMPHOID B-CELL MALIGNANCY:A SINGLE CENTER ANALYSIS IN THE REAL WORLD

Detalles Bibliográficos
Autores principales: LV, Mengnan, He, Yi, Yang, Donglin, MA, Qiaoling, Pang, Aiming, Zhai, Weihua, Wei, Jialin, Huang, Yong, Chen, Xin, Zhang, Guixin, Feng, Sizhou, Han, Mingzhe, Zhang, Rongli, Jiang, Erlie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430324/
http://dx.doi.org/10.1097/01.HS9.0000973784.59213.73
_version_ 1785090935797841920
author LV, Mengnan
He, Yi
Yang, Donglin
MA, Qiaoling
Pang, Aiming
Zhai, Weihua
Wei, Jialin
Huang, Yong
Chen, Xin
Zhang, Guixin
Feng, Sizhou
Han, Mingzhe
Zhang, Rongli
Jiang, Erlie
author_facet LV, Mengnan
He, Yi
Yang, Donglin
MA, Qiaoling
Pang, Aiming
Zhai, Weihua
Wei, Jialin
Huang, Yong
Chen, Xin
Zhang, Guixin
Feng, Sizhou
Han, Mingzhe
Zhang, Rongli
Jiang, Erlie
author_sort LV, Mengnan
collection PubMed
description
format Online
Article
Text
id pubmed-10430324
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-104303242023-08-17 PB1731: INOTUZUMAB OZOGAMICIN IN LYMPHOID B-CELL MALIGNANCY:A SINGLE CENTER ANALYSIS IN THE REAL WORLD LV, Mengnan He, Yi Yang, Donglin MA, Qiaoling Pang, Aiming Zhai, Weihua Wei, Jialin Huang, Yong Chen, Xin Zhang, Guixin Feng, Sizhou Han, Mingzhe Zhang, Rongli Jiang, Erlie Hemasphere Publication Only Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10430324/ http://dx.doi.org/10.1097/01.HS9.0000973784.59213.73 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Publication Only
LV, Mengnan
He, Yi
Yang, Donglin
MA, Qiaoling
Pang, Aiming
Zhai, Weihua
Wei, Jialin
Huang, Yong
Chen, Xin
Zhang, Guixin
Feng, Sizhou
Han, Mingzhe
Zhang, Rongli
Jiang, Erlie
PB1731: INOTUZUMAB OZOGAMICIN IN LYMPHOID B-CELL MALIGNANCY:A SINGLE CENTER ANALYSIS IN THE REAL WORLD
title PB1731: INOTUZUMAB OZOGAMICIN IN LYMPHOID B-CELL MALIGNANCY:A SINGLE CENTER ANALYSIS IN THE REAL WORLD
title_full PB1731: INOTUZUMAB OZOGAMICIN IN LYMPHOID B-CELL MALIGNANCY:A SINGLE CENTER ANALYSIS IN THE REAL WORLD
title_fullStr PB1731: INOTUZUMAB OZOGAMICIN IN LYMPHOID B-CELL MALIGNANCY:A SINGLE CENTER ANALYSIS IN THE REAL WORLD
title_full_unstemmed PB1731: INOTUZUMAB OZOGAMICIN IN LYMPHOID B-CELL MALIGNANCY:A SINGLE CENTER ANALYSIS IN THE REAL WORLD
title_short PB1731: INOTUZUMAB OZOGAMICIN IN LYMPHOID B-CELL MALIGNANCY:A SINGLE CENTER ANALYSIS IN THE REAL WORLD
title_sort pb1731: inotuzumab ozogamicin in lymphoid b-cell malignancy:a single center analysis in the real world
topic Publication Only
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430324/
http://dx.doi.org/10.1097/01.HS9.0000973784.59213.73
work_keys_str_mv AT lvmengnan pb1731inotuzumabozogamicininlymphoidbcellmalignancyasinglecenteranalysisintherealworld
AT heyi pb1731inotuzumabozogamicininlymphoidbcellmalignancyasinglecenteranalysisintherealworld
AT yangdonglin pb1731inotuzumabozogamicininlymphoidbcellmalignancyasinglecenteranalysisintherealworld
AT maqiaoling pb1731inotuzumabozogamicininlymphoidbcellmalignancyasinglecenteranalysisintherealworld
AT pangaiming pb1731inotuzumabozogamicininlymphoidbcellmalignancyasinglecenteranalysisintherealworld
AT zhaiweihua pb1731inotuzumabozogamicininlymphoidbcellmalignancyasinglecenteranalysisintherealworld
AT weijialin pb1731inotuzumabozogamicininlymphoidbcellmalignancyasinglecenteranalysisintherealworld
AT huangyong pb1731inotuzumabozogamicininlymphoidbcellmalignancyasinglecenteranalysisintherealworld
AT chenxin pb1731inotuzumabozogamicininlymphoidbcellmalignancyasinglecenteranalysisintherealworld
AT zhangguixin pb1731inotuzumabozogamicininlymphoidbcellmalignancyasinglecenteranalysisintherealworld
AT fengsizhou pb1731inotuzumabozogamicininlymphoidbcellmalignancyasinglecenteranalysisintherealworld
AT hanmingzhe pb1731inotuzumabozogamicininlymphoidbcellmalignancyasinglecenteranalysisintherealworld
AT zhangrongli pb1731inotuzumabozogamicininlymphoidbcellmalignancyasinglecenteranalysisintherealworld
AT jiangerlie pb1731inotuzumabozogamicininlymphoidbcellmalignancyasinglecenteranalysisintherealworld